SCHEMBL3970918

SCHEMBL3970918

C=COC[C@@H]1CC[C@H](n2cc(Br)c(=O)[nH]c2=O)O1

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.49
POLB P06746 1/20 0.49
KMT2A Q03164 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
BCHE P06276 1/20 0.41
PYGM P11217 1/20 0.40
P2RY6 Q15077 2/20 0.36
TK1 P04183 4/20 0.35
CYP3A4 P08684 2/20 0.35
TSHR P16473 2/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
TYMS P04818 1/20 0.34
P2RY2 P41231 1/20 0.34
P2RY4 P51582 1/20 0.34
CYP1A2 P05177 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2633814 0.87 BCHE (0.52) BCHETK1TSHR
SCHEMBL3972864 0.87 ALDH1A1 (0.52) ALDH1A1POLBKMT2ASMN1; SMN2BCHE
SCHEMBL19389398 0.81 TK1 (0.52) ALDH1A1POLBKMT2ASMN1; SMN2TK1
SCHEMBL10380346 0.80 ALDH1A1 (0.56) ALDH1A1POLBKMT2ASMN1; SMN2PYGM
SCHEMBL2035541 0.80 ALDH1A1 (0.56) ALDH1A1POLBKMT2ASMN1; SMN2PYGM
SCHEMBL24695865 0.80 ALDH1A1 (0.56) ALDH1A1POLBKMT2ASMN1; SMN2PYGM
SCHEMBL3066260 0.80 SMN1; SMN2 (0.44) ALDH1A1POLBKMT2ASMN1; SMN2PYGM
SCHEMBL3078239 0.79 ALDH1A1 (0.42) ALDH1A1POLBKMT2ASMN1; SMN2PYGM
SCHEMBL9447734 0.79 POLB (0.46) ALDH1A1POLBKMT2ASMN1; SMN2BCHE
SCHEMBL3066252 0.79 SMN1; SMN2 (0.44) ALDH1A1POLBKMT2ASMN1; SMN2PYGM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2054406-A1 NUCLEOSIDES FOR SUPPRESSING OR REDUCING THE DEVELOPMENT OF RESISTANCE IN CYTOSTATIC THERAPY RESprotect GmbH (DE) 2009-05-06 EP disclosed
WO-2008017515-A1 NUCLEOSIDES FOR SUPPRESSING OR REDUCING THE DEVELOPMENT OF RESISTANCE IN CYTOSTATIC THERAPY RESPROTECT GMBH (DE) 2008-02-14 WO disclosed